Inactive

The Regional Health Contracting Office - Central is issuing this Sources Sought Notice on behalf of Brooke Army Medical Center, Joint Base San Antonio (JBSA) - Fort Sam Houston, Texas. Any responses t... The Regional Health Contracting Office - Central is issuing this Sources Sought Notice on behalf of Brooke Army Medical Center, Joint Base San Antonio (JBSA) - Fort Sam Houston, Texas. Any responses to this Sources Sought Notice will be used for planning purposes only. The type of solicitation that will be issued, to include a sole source solicitation (provided that it is otherwise justified and approved in accordance with agency procedures), will be based on the responses to this notice. This notice is not a solicitation of binding offers, nor is it a notice to proceed. Brooke Army Medical Center has a requirement for Histology testing with Immunohistochemistry, In-Situ Hybridizations, and Special Stains. The testing is currently conducted on Roche Diagnostics equipment (e.g., the Ventana). Vendors that consider themselves capable of providing the required testing are invited to submit a capability statement via email for the Government to consider. This capability statement shall include the following information. If the capability statement does not address ALL of the points below, the vendor will not be considered as capable of providing the required testing: 1. Vendor name (to include CAGE code and DUNS number), Point of Contact (to include email address and phone number), and business size under NAICS code 325413 (along with any socio-economic subcategories). 2. Documentation that demonstrates the vendor's ability to provide ALL Histology testing, as listed in the attached spreadsheet. NOTE: There are two tabs on the spreadsheet. The material numbers listed are Roche Diagnostics catalog numbers and are given as a point of reference / to allow for comparison against an interested vendor's own catalog. This documentation shall include information such as: a. Food and Drug Administration (FDA) approval where applicable; b. How the vendor's equipment meets or exceeds the salient characteristics on the attached spreadsheet and what tests (reagents/consumables) they are able to provide; c. Any software that would interface with existing Department of Defense information systems/networks in a medical treatment facility must have successfully undergone the Risk Management Framework (RMF) review, and be in compliance with the Defense Health Agency guidance on this subject. Vendors shall submit either evidence of compliance with this guidance (to include a point of contact at a DoD facility that can verify that the model being proposed has gone through the process) or other acknowledgment they are willing and able to go through this process. 3. Timeline for installation of equipment at BAMC from official notice to proceed (i.e., number of days from receipt of notice to completed installation on site). Capability statements shall be submitted no later than 12:00pm (noon) CST on 10 September 2020 in order to be considered.